the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments. Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.
Study Type
OBSERVATIONAL
Enrollment
2,000
PRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices
Istituto Clinico San Siro (satellite center)
Milan, Italia, Italy
RECRUITINGIRCCS Ospedale Galeazzi-Sant'Ambrogio (coordinator)
Milan, Italy, Italy
RECRUITINGChange in Visual Analog Scale
Pain will be measured with Visual Analog Scale (0-10, where 0 rapresents absence of pain and 10 the maximum pain possible) before and after treatment.
Time frame: Change between baseline and 12 months
Change in Tegner Activity Scale
Level of activity will be recorded using Tegner activity scale (0-10, where 0 represents absence of physical activity and 10 represents national level sport activity) before and after treatment
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in Knee injury and Osteoarthritis Outcome Score for patients affected by knee osteoarthritis
The level of symptoms, pain, activity, sport and quality of life will be assessed using Knee injury and Osteoarthritis Outcome Score (0-100, where 0 represents the worst outcome and 100 the best outcome) before and after treatment.
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in Hip injury and Osteoarthritis Outcome Score for patients affected by hip osteoarthritis
The level of symptoms, pain, activity, sport and quality of life will be assessed using Hip injury and Osteoarthritis Outcome Score (0-100, where 0 represents the worst condition and 100 the best condition) before and after treatment.
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in QuickDASH (Disabilities of the Arm, Shoulder and Hand) and SPADI (Shoulder Pain and Disability Index ) questionnaire for patients affected by shoulder disorders
The level of symptoms, pain, activity, sport and quality of life will be assessed using Hip injury and Osteoarthritis Outcome Score (0-100, where 0 represents the worst condition and 100 the best condition) before and after treatment.
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in the Shoulder Pain and Disability Index (SPADI) for patients affected by shoulder disorders
Pain level and extent of difficulty with the activity of daily living will be assessed using SPADI (0-100, where 100 represents the worst condition and 0 the best condition) in patients affected by shoulder disorders.
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in Victorian Institute of Sport Assessment for Patellar tendon (VISA-P) score for patients affected by patellar tendon disorders
Symptoms, ability to perform daily and sport activities will be measured using VISA-P score (0-100, where 0 represents the worst condition and 100 the best condition) in patients affected by patellar tendon disorders.
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in Lysholm Knee Score for patients affected by patellar tendon disorders
Lysholm knee score will be used to assess the condition of the knee in patients affected by patellar tendon disorders (0-100, where 0 represents the worst condition and 100 the best condition).
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in Foot Function Index (FFI) for patients affected by ankle and foot disorders
Pain, Disability, and Activity Limitation in patients affected by foot and ankle disorders will be measured using FFI (0-100, where 100 represents the worst condition and 0 the best condition).
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in Victorian Institute of Sport Assessment for Achilles tendon (VISA-A) score for patients affected by Achilles tendon disorders
Symptoms, ability to perform daily and sport activities will be measured in patients affected by Achilles tendon disorders using VISA-A score (0-100, where 0 represents the worst condition and 100 the best condition).
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Change in Patient-Rated Tennis Elbow Evaluation (PRTEE) scale for patients affected by elbow disorders
Pain and function will be measured in patients affected by elbow disorders using PRTEE score (0-100, where 100 represents the worst condition and 0 the best condition).
Time frame: Changes between baseline and 2-, 6- 12 and 24-month assessments
Platelet count in Platelet-rich Plasma (PRP)
For each patient receiving PRP, platelet count will be measured in order to evaluate possible correlation between the product composition and the clinical outcomes
Time frame: Baseline only
Nucleated cell counts in adipose tissue- and bone marrow-derived orthobiologics
For each patient receiving adipose tissue- or bone marrow-derived orthobiologics, the number of nucleated cells will be determined to evaluate possible correlation between the product composition and the clinical outcomes
Time frame: Baseline only
Change in Visual Analog Scale
Pain will be measured with Visual Analog Scale (0-10, where 0 rapresents absence of pain and 10 the maximum pain possible) before and after treatment.
Time frame: Changes between baseline and 2-, 6- and 24-month assessments
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.